Status: current, Defined. Date: 31-Mar 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1832371000168113 | asfotase alfa (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1832381000168111 | asfotase alfa | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| asfotase alfa | Is a | medicinal product | true | Inferred relationship | Some | ||
| asfotase alfa | has intended active ingredient | asfotase alfa | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| asfotase alfa 40 mg/mL injection, vial | Is a | True | asfotase alfa | Inferred relationship | Some | |
| asfotase alfa 80 mg/0.8 mL injection, vial | Is a | True | asfotase alfa | Inferred relationship | Some | |
| asfotase alfa 12 mg/0.3 mL injection, vial | Is a | True | asfotase alfa | Inferred relationship | Some | |
| asfotase alfa 28 mg/0.7 mL injection, vial | Is a | True | asfotase alfa | Inferred relationship | Some | |
| asfotase alfa 18 mg / 0.45 mL injection, 0.45 mL vial (medicinal product unit of use) | Is a | True | asfotase alfa | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR